{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:33:23Z","timestamp":1768995203130,"version":"3.49.0"},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,10,9]],"date-time":"2008-10-09T00:00:00Z","timestamp":1223510400000},"content-version":"vor","delay-in-days":1743,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Dialysis"],"published-print":{"date-parts":[[2004,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Oral iron is typically insufficient for the iron deficiency of hemodialysis patients. Intravenous (IV) iron is well tolerated by most patients and non\u2010dextran\u2010containing iron preparations are associated with few allergic reactions. However, there is the potential for an increased risk of infection with IV iron that appears to increase bacterial growth as well as inhibit the host's innate immune response to bacterial infection. Clinical studies suggest a link between iron therapy and infection. Practicing nephrologists should be aware of this issue, but should not hesitate to use IV iron in iron\u2010deficient patients while avoiding the development of iron overload and administration of iron to patients who have active infection.<\/jats:p>","DOI":"10.1111\/j.1525-139x.2004.17115.x","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T09:57:24Z","timestamp":1284631044000},"page":"57-60","source":"Crossref","is-referenced-by-count":25,"title":["Intravenous Iron and the Risk of Infection in End\u2010Stage Renal Disease Patients"],"prefix":"10.1111","volume":"17","author":[{"given":"Mark A.","family":"Perazella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ursula C.","family":"Brewster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Perazella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,10,9]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1681\/ASN.V12112465","article-title":"Death, hospitalization and economic associations among incident hemodialysis patients with hematocrit levels of 36% to 39%","volume":"12","author":"Collins AJ","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_3_2","first-page":"S182","article-title":"NKF\u2010K\/DOQI clinical practice guidelines of anemia of chronic kidney disease: update 2000","volume":"39","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0272-6386(95)90151-5"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.1999.99030.x"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(99)70183-6"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(03)00373-1"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V113530"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00191543"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.1999.v34.aajkd0344b0047"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/3.6.1127"},{"key":"e_1_2_5_12_2","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1128\/iai.51.3.723-730.1986","article-title":"Effect of iron compounds on antibacterial function of human polymorphs","volume":"15","author":"Ward CG","year":"1986","journal-title":"Infect Immunol"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.ndt.a027405"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/15.11.1827"},{"key":"e_1_2_5_15_2","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/clinchem\/45.6.898","article-title":"Comparison of methods used to measure serum iron in the presence of iron gluconate or iron dextran","volume":"46","author":"Seligman P","year":"1999","journal-title":"Clin Chem"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/516481"},{"key":"e_1_2_5_17_2","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1681\/ASN.V391541","article-title":"Infectious morbidity and defects of phagocytic function in end\u2010stage renal disease: a review","volume":"3","author":"Vanholder R","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(84)93955-0"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V94655"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.2003.00125.x"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115407"},{"key":"e_1_2_5_22_2","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/iai.51.2.373-377.1986","article-title":"Bacteriacidal effect of lactoferrin on Legionella pneumophila","volume":"51","author":"Bortner C","year":"1986","journal-title":"Infect Immunol"},{"key":"e_1_2_5_23_2","first-page":"1015","article-title":"Iron overload, but not treatment with deferoxamine favours the development of septicemia in patients on maintenance hemodialysis","volume":"65","author":"Seifert A","year":"1987","journal-title":"Q J Med"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/ndt\/4.10.883","article-title":"Critical role of iron overload in the increased susceptibility of haemodialysis patients to bacterial infection. Beneficial effects of desferriozamine","volume":"4","author":"Tieleman CL","year":"1989","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/5.2.130"},{"key":"e_1_2_5_26_2","first-page":"377","article-title":"Risk factors for bacterial infections in chronic hemodialysis adult patients: a multicentre prospective study","volume":"10","author":"Hoen B","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"e_1_2_5_27_2","first-page":"190A","article-title":"Frequent IV iron dosing is associated with higher infectious deaths [abstract]","volume":"8","author":"Collins A","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_28_2","first-page":"205A","article-title":"IV iron dosing patterns and mortality [abstract]","volume":"9","author":"Collins A","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_29_2","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1681\/ASN.V133734","article-title":"Iron administration and clinical outcomes in hemodialysis patients","volume":"13","author":"Feldman HI","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_30_2","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1681\/ASN.V95869","article-title":"EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients","volume":"9","author":"Hoen B","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_31_2","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1681\/ASN.V113530","article-title":"Optimization of epoetin therapy with the intravenous iron therapy in hemodialysis patients","volume":"11","author":"Besarab A","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1982.106"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.296"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-139X.1999.99028.x"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.232"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1991.40"}],"container-title":["Seminars in Dialysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1525-139X.2004.17115.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1525-139X.2004.17115.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T20:29:35Z","timestamp":1697142575000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1525-139X.2004.17115.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["10.1111\/j.1525-139X.2004.17115.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1525-139x.2004.17115.x","archive":["Portico"],"relation":{},"ISSN":["0894-0959","1525-139X"],"issn-type":[{"value":"0894-0959","type":"print"},{"value":"1525-139X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}